Header cover image

Taiwanese Pharmaceuticals & Biotech Big Green Snowflakes

Results

128

0 new

Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).

128 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
6645
Kim Forest Enterprise		NT$23.65-0.6%-42.4%NT$1.3bn/aPS2.7xn/a0.4%
6976
Acepodia		NT$23.40-1.7%-20.4%NT$13.7bn/aPS794.1xn/an/a
4172
InnoPharmax		NT$15.60-1.3%-9.0%NT$1.5bn/aPS42.9xn/an/a
4186
Taiwan Advance Bio-Pharmaceutical		NT$15.85-1.2%5.7%NT$1.4bn/aPE66.6xn/an/a
6696
Lin BioScience		NT$143.00-0.3%28.8%NT$11.1bn/aPB4.4xn/an/a
6704
Gwo Xi Stem Cell Applied Technology		NT$26.20-3.0%-20.1%NT$2.5bn/aPS16.7xn/an/a
6564
Enimmune		NT$24.90-4.2%-34.4%NT$1.9bn/aPS35.3xn/an/a
6467
Taho Pharmaceuticals		NT$61.001.0%n/aNT$3.2bn/aPB12.8xn/an/a
3176
Medigen Biotechnology		NT$35.700%-12.7%NT$5.0bn/aPS3.5xn/an/a
7808
BIONET Therapeutics		NT$59.50-0.8%n/aNT$4.2bn/aPS96.1xn/an/a
4166
Orient Pharma		NT$38.000%86.3%NT$8.5bn/aPE71.2xn/an/a
6617
Gongwin Biopharm Holdings		NT$116.50-3.3%-42.0%NT$14.6bn/aPS464.3xn/an/a
6838
Formosa Pharmaceuticals		NT$36.05-1.0%-36.6%NT$5.5bn/aPS39.6xn/an/a
6634
Sinew Pharma		NT$52.20-3.2%-23.1%NT$3.7bn/aPB2.9xn/an/a
6875
Pharmosa Biopharm		NT$61.000.7%-41.6%NT$7.9bn/aPS155.9xn/an/a
6550
Polaris Group		NT$46.05-9.5%-34.7%NT$36.1bn/aPS454.2xn/an/a
6677
Anxo Pharmaceutical		NT$25.405.2%-48.1%NT$1.4bn/aPS1.6xn/a1.6%
7595
Pharmigene		NT$14.20-4.7%-30.4%NT$716.6mn/aPS5.6xn/an/a
7561
Bioray Biotech		NT$24.60-0.8%-10.5%NT$733.9mn/aPS4xn/a0%
4120
Orient EuroPharma		NT$54.804.6%32.4%NT$4.8bn/aPE24.9xn/a1.8%
6576
Foresee Pharmaceuticals		NT$86.001.7%-15.7%NT$13.3bNT$126.50PS38.4xE6.4%n/a
6932
Mercury Biopharmaceutical		NT$16.251.6%2.2%NT$6.8bn/aPS1190.7xn/an/a
6661
Welgene BiotechLtd		NT$23.151.8%3.3%NT$539.5mn/aPS1.7xn/a0%
6562
UBI Pharma		NT$14.251.8%-62.3%NT$1.7bn/aPE2097.4xn/a0%
Page 4 of 6